Share

June 12, 2018; 90 (24) Article

Use of medical care biases associations between Parkinson disease and other medical conditions

Anat Gross, Brad A. Racette, Alejandra Camacho-Soto, Umber Dube, Susan Searles Nielsen
First published May 9, 2018, DOI: https://doi.org/10.1212/WNL.0000000000005678
Full PDF
Short Form
Citation
Permissions

Make Comment

See Comments

Downloads
171

Share

Article Information

vol. 90 no. 24 e2155-e2165
DOI: 
https://doi.org/10.1212/WNL.0000000000005678
PubMed: 
29743207
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received August 31, 2017
  • Accepted in final form March 30, 2018
  • First Published May 9, 2018.

Article Versions

Copyright & Usage: 
© 2018 American Academy of Neurology

Author Disclosures

    1. Anat Gross, MS,
    2. Brad A. Racette, MD,
    3. Alejandra Camacho-Soto, MD,
    4. Umber Dube, PhC and
    5. Susan Searles Nielsen, PhD
  1. Anat Gross, MS,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Brad A. Racette, MD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. "Methods of Lowering the Risk for Developing a Neurodegenerative Disease", provisional patent application submitted. This patent application supports patent protection for the use of certain classes of immunosuppressants for neuroprotection in PD.

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other activities:

    1. University of Michigan: honorarium for mentorship workshop American Academy of Neurology: honorarium for teaching botulinum toxin injection course

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. All the below are multi-center clinical trials: Allergan Teva Pharmaceuticals Civitas Therapeutics Ipsen US World Meds

    Research Support, Government Entities:

    1. NIH R01ES025991 (PI-Racette) 7/1/2015 ? 6/30/2020 ?Motor and Cognitive Health Outcomes in a Mn-Exposed African Community? R01 ES021488 1/1/2013-12/31/2017 ?Imaging Biomarkers of Neurotoxicity in Welders? K24 NS060825 (PI-Racette) 4/1/2009 ? 6/30/19 ?Epidemiology and Biomarkers of Parkinsonism in Welders? R01ES021488-02S1 8/28/2014-8/27/2015 ?Imaging Biomarkers of Neurotoxicity in Welders? R01ES025991-02S1 (Racette) 05/01/2017 ? 10/31/2020 ?Virtual Consortium for Translational/Transdisciplinary Environmental Research (ViCTER)? R01ES026891 (PI-Racette) 9/1/2017 - 8/31/2022 ?Manganese-Induced Neurotoxic Effects Research in South Africa (MINERS)?

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Michael J. Fox Foundation American Parkinson Disease Association

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. Cassiday Schade, LLP- consultant Brown and James- consultant

  3. Alejandra Camacho-Soto, MD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Funding source: Rehabilitation Medicine Scientist Training Program (RMSTP) Fellowship NIH K12 Grant number: 5K12 HD001097-19 Role: PI/Fellow Years: 2015-2017

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Umber Dube, PhC and
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Susan Searles Nielsen, PhD
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. (1) International Journal of Molecular Epidemiology and Genetics, Associate Board Member, 2012-present.

    Patents:

    1. (1) Provisional patent application submitted for methods of lowering the risk for developing a neurodegenerative disease.

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) NIH-NIEHS, R01ES025991, Co-Investigator, 2015-present, (2) NIH-NIEHS, R01ES021488, Data Analyst, 2014-present, (3) NIH- NIEHS, R21ES024120, 2014-2016, (4) NIH-NIEHS, R01ES017462, Data Analyst, 2013-2015, (5) NIH-NIEHS, P42ES004696, Data Analyst, 2010-2014.

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. (1) Michael J. Fox Foundation, (2) American Parkinson Disease Association

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Department of Neurology (A.G., B.A.R., A.C.-S., U.D., S.S.N.), Washington University School of Medicine, St. Louis, MO; and School of Public Health (B.A.R.), Faculty of Health Sciences, University of the Witwatersrand, Parktown, South Africa.
  1. Correspondence
    Dr. Searles Nielsen searles-nielsens{at}wustl.edu

Article usage

Article usage: May 2018 to October 2023

AbstractFullPdfSource
May 2018672013Highwire
Jun 201845613584Highwire
Jul 20181112715Highwire
Aug 20183856Highwire
Sep 20183263Highwire
Oct 20183862Highwire
Nov 20182635Highwire
Dec 201837106Highwire
Jan 20193833Highwire
Feb 20192311Highwire
Mar 20192141Highwire
Apr 20192743Highwire
May 20191542Highwire
Jun 20191123Highwire
Jul 20191100Highwire
Aug 2019933Highwire
Sep 2019722Highwire
Oct 20191210Highwire
Nov 20191811Highwire
Dec 20191610Highwire
Jan 20201401Highwire
Feb 20202442Highwire
Mar 20202720Highwire
Apr 20203900Highwire
May 20202500Highwire
Jun 20201400Highwire
Jul 20201700Highwire
Aug 2020900Highwire
Sep 20202000Highwire
Oct 20201400Highwire
Nov 20203410Highwire
Dec 20202611Highwire
Jan 20212010Highwire
Feb 20211030Highwire
Mar 20212741Highwire
Apr 20211300Highwire
May 20211010Highwire
Jun 20212462Highwire
Jul 20212210Highwire
Aug 20212402Highwire
Sep 20211100Highwire
Oct 20212300Highwire
Nov 20212400Highwire
Dec 20212800Highwire
Jan 20222800Highwire
Feb 20222410Highwire
Mar 20222200Highwire
Apr 2022911Highwire
May 20221900Highwire
Jun 20222900Highwire
Jul 20222423Highwire
Aug 20221500Highwire
Sep 2022700Highwire
Oct 20222000Highwire
Nov 20222500Highwire
Dec 20222800Highwire
Jan 20231200Highwire
Feb 2023900Highwire
Mar 20231400Highwire
Apr 2023900Highwire
May 20232002Highwire
Jun 20231811Highwire
Jul 20231632Highwire
Aug 20231100Highwire
Sep 2023700Highwire
Oct 20231000Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. [email protected]
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top

More Online

CME Course

Related Articles

Topics Discussed

Alert Me

Recommended articles